Delivery Order HR001113D0002-HHSO100201500007U
Award Date 2/20/15
Potential Completion Date 8/19/16
Potential Value $2M
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Newark, DE, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to JPT Peptide Technologies GmbH, a foreign-owned for-profit manufacturer of custom peptides and related products. The contract is valued at $7,975.75 and requires the delivery of custom peptides of the Zaire Ebola virus glycoprotein, as individual and pooled aliquots, with quality control via liquid chromatography-mass...
- <p>This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Boston Bioscience Inc. on September 27, 2012. The contract, valued at $35,705.00, is for the delivery of EBOLA GP (Z) CARBOXYL TERMINUS ACID PEPTIDES, 15 AMINO ACIDS IN LENGTH. The contract has a completion date of October 3, 2012 and does not utilize a set-aside designation.</p>
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $99,612.73 firm fixed price purchase order contract to Fraunhofer USA, Inc. to produce ectodomain virus-like particles (VLPs) for the hemagglutinin (HA) molecules of influenza virus strains H1, H3, H5, and H7. The contract was not set aside and has a completion date of June 20, 2018. Fraunhofer USA, Inc. is a non-profit applied research and development...
- This is a $1,628,690,592.00 definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Bavarian Nordic A/S, a for-profit biotechnology company based in Denmark. The contract has a firm fixed price pricing type and an ultimate completion date of September 26, 2027. It is not a set-aside contract. Bavarian Nordic A/S is providing the government with various goods and services, including endpoint titer analysis services involving...
- This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to IDT Biologika GMBH, a foreign-owned, for-profit biotechnology company based in Germany. The contract is a $70,108.14 delivery order under a larger indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle for manufacturing and characterization services for vaccines and other biologics for infectious diseases. The...
- This is a federal delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to IDT Biologika GMBH, a foreign-owned, for-profit biotechnology company based in Germany. The contract, valued at a ceiling of $2,723,700.00, is for vaccine manufacturing and characterization services to support infectious disease research and pandemic preparedness efforts. Specific work includes the development,...
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Institut National De Recherche Biomedicale, a non-profit organization based in the Democratic Republic of the Congo. The contract, valued at $146,850.00, does not have a set-aside designation. The contract award indicates that Institut National De Recherche Biomedicale has provided a range of research, surveillance, testing, training, and administrative...
- This is a delivery order awarded by the Centers for Disease Control and Prevention (CDC) under the Safety and Healthcare Epidemiology Prevention Research Development (SHEPheRD) indefinite delivery, indefinite quantity (IDIQ) contract. The contract was awarded to Health Core, Inc., a for-profit organization, to provide services related to the Ebola virus response, as indicated by the solicitation number "RFTOP 2015-010 AUR EBOLA". The contract has a firm fixed price of $491,954.00 and a...
- <p>The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $12.2 million delivery order contract to Leidos Biomedical Research Inc. to support research, development, and production efforts related to Ebola bispecific antibody development. As the prime contractor, Leidos Biomedical Research will perform work at its place of performance in Fort Detrick, Maryland under a cost plus fixed fee contract running from September 2022 through July 2028.</p>
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Battelle Memorial Institute, a nonprofit research and development organization. The $5,638,781.12 cost-plus-award-fee contract supports the evaluation of Ebola virus and other filovirus vaccines in a novel ferret model. This work is part of the NIAID's broader efforts to develop medical countermeasures against...